FR2500755B1 - - Google Patents

Info

Publication number
FR2500755B1
FR2500755B1 FR8200025A FR8200025A FR2500755B1 FR 2500755 B1 FR2500755 B1 FR 2500755B1 FR 8200025 A FR8200025 A FR 8200025A FR 8200025 A FR8200025 A FR 8200025A FR 2500755 B1 FR2500755 B1 FR 2500755B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8200025A
Other languages
French (fr)
Other versions
FR2500755A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Industri AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Industri AS filed Critical Novo Industri AS
Publication of FR2500755A1 publication Critical patent/FR2500755A1/fr
Application granted granted Critical
Publication of FR2500755B1 publication Critical patent/FR2500755B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6435Plasmin (3.4.21.7), i.e. fibrinolysin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21007Plasmin (3.4.21.7), i.e. fibrinolysin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood
    • Y10S530/83Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR8200025A 1981-01-05 1982-01-04 Compositions de plasmine stabilisee, leur procede de preparation et leurs applications, notamment comme agents de balayage scintigraphique Granted FR2500755A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8100133 1981-01-05

Publications (2)

Publication Number Publication Date
FR2500755A1 FR2500755A1 (fr) 1982-09-03
FR2500755B1 true FR2500755B1 (US20030220297A1-20031127-C00074.png) 1984-01-13

Family

ID=10518790

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8200025A Granted FR2500755A1 (fr) 1981-01-05 1982-01-04 Compositions de plasmine stabilisee, leur procede de preparation et leurs applications, notamment comme agents de balayage scintigraphique

Country Status (8)

Country Link
US (1) US4462980A (US20030220297A1-20031127-C00074.png)
BE (1) BE891679A (US20030220297A1-20031127-C00074.png)
CH (1) CH648862A5 (US20030220297A1-20031127-C00074.png)
DE (1) DE3200058A1 (US20030220297A1-20031127-C00074.png)
DK (1) DK982A (US20030220297A1-20031127-C00074.png)
FR (1) FR2500755A1 (US20030220297A1-20031127-C00074.png)
IT (1) IT1194135B (US20030220297A1-20031127-C00074.png)
NL (1) NL8200004A (US20030220297A1-20031127-C00074.png)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
US5288489A (en) * 1991-08-28 1994-02-22 Orion Therapeutic Systems, Inc. Fibrinolysis and fibrinogenolysis treatment
US6355243B1 (en) 1999-11-13 2002-03-12 Bayer Corporation Method of thrombolysis by local delivery of active plasmin
US7544500B2 (en) * 1999-11-13 2009-06-09 Talecris Biotherapeutics, Inc. Process for the production of a reversibly inactive acidified plasmin composition
US6964764B2 (en) * 1999-11-13 2005-11-15 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
US6969515B2 (en) 1999-11-13 2005-11-29 Talecris Biotherapeutics, Inc. Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
AU2002239366A1 (en) * 2000-11-28 2002-06-11 Geetha Kassam Anti-angiogenic polypeptides
US20040142897A1 (en) * 2001-11-28 2004-07-22 Waisman David M. Compositions and methods for inhibiting tumor growth and metastasis
US7250271B2 (en) * 2001-11-28 2007-07-31 David Waisman Anti-angiogenesis methods, compositions and uses therefor
GB0228409D0 (en) * 2002-12-06 2003-01-08 Thromb X Nv Pharmacological vitreolysis
CA2514873C (en) 2002-12-13 2012-01-03 David Waisman Compositions and methods for inhibiting tumor growth and metastasis
CA2610252A1 (en) * 2005-06-14 2006-12-21 Nihon Medi-Physics Co., Ltd. Radioactive diagnostic imaging agent
US8617863B2 (en) * 2008-06-04 2013-12-31 Grifols Therapeutics Inc. Composition, method, and kit for preparing plasmin
PT2403865E (pt) 2009-03-03 2015-11-18 Grifols Therapeutics Inc Métodos de preparação de plasminogénio
RU2564131C2 (ru) 2009-07-10 2015-09-27 ТромбоДженикс НВ Варианты плазминогена и плазмина
BR112013017172A2 (pt) 2011-01-05 2016-10-11 Thrombogenics Nv variantes de plasminogênio e plasmina
KR20140064841A (ko) 2011-08-12 2014-05-28 쓰롬보제닉스 엔.브이. 플라스미노겐 변이체 및 플라스민 변이체

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950513A (en) * 1965-12-03 1976-04-13 Novo Terapeutisk Laboratorium A/S Process of stabilizing therapeutically useful plasmin solutions
US3720761A (en) * 1968-10-14 1973-03-13 W Hunter Injectable radio-pharmaceutical scanning agent and preparation
US3863004A (en) * 1972-03-20 1975-01-28 Mallinckrodt Chemical Works Denatured macroprotein with divalent tin for tagging with technetium-99m and method of preparation
US4062933A (en) * 1975-05-27 1977-12-13 Mallinckrodt, Inc. Colloidal compositions with protective agents suitable for radioactive labeling
US4048296A (en) * 1975-05-27 1977-09-13 Mallinckrodt, Inc. Radiopharmaceutical scanning agents
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
IT8125932A0 (it) 1981-12-31
NL8200004A (nl) 1982-08-02
BE891679A (fr) 1982-07-05
IT1194135B (it) 1988-09-14
DE3200058A1 (de) 1982-11-04
DK982A (da) 1982-07-06
FR2500755A1 (fr) 1982-09-03
US4462980A (en) 1984-07-31
CH648862A5 (de) 1985-04-15

Similar Documents

Publication Publication Date Title
FR2505908B1 (US20030220297A1-20031127-C00074.png)
FR2505097B1 (US20030220297A1-20031127-C00074.png)
FR2505543B1 (US20030220297A1-20031127-C00074.png)
FR2506662B1 (US20030220297A1-20031127-C00074.png)
FR2497975B1 (US20030220297A1-20031127-C00074.png)
FR2502205B1 (US20030220297A1-20031127-C00074.png)
CH655527B (US20030220297A1-20031127-C00074.png)
FR2500755B1 (US20030220297A1-20031127-C00074.png)
FR2502209B2 (US20030220297A1-20031127-C00074.png)
CH665743GA3 (US20030220297A1-20031127-C00074.png)
FR2502113B1 (US20030220297A1-20031127-C00074.png)
FR2504209B1 (US20030220297A1-20031127-C00074.png)
FR2518734B1 (US20030220297A1-20031127-C00074.png)
IN155115B (US20030220297A1-20031127-C00074.png)
FR2506561B1 (US20030220297A1-20031127-C00074.png)
DE3280382D1 (US20030220297A1-20031127-C00074.png)
FR2504904B3 (US20030220297A1-20031127-C00074.png)
FR2503689B1 (US20030220297A1-20031127-C00074.png)
FR2504265B1 (US20030220297A1-20031127-C00074.png)
FR2505961B1 (US20030220297A1-20031127-C00074.png)
FR2505327B1 (US20030220297A1-20031127-C00074.png)
FR2505285B1 (US20030220297A1-20031127-C00074.png)
JPS57174810U (US20030220297A1-20031127-C00074.png)
FR2511420B3 (US20030220297A1-20031127-C00074.png)
FR2502660B1 (US20030220297A1-20031127-C00074.png)

Legal Events

Date Code Title Description
ST Notification of lapse